-
1
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789.
-
(2007)
N. Engl. J. Med.
, vol.356
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
-
4
-
-
0035912936
-
Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system
-
Michael Y, Snowden MJ, Chowdhry BZ, et al. Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system. Int. J. Pharmaceutics. 2001; 221: 165-174.
-
(2001)
Int. J. Pharmaceutics.
, vol.221
, pp. 165-174
-
-
Michael, Y.1
Snowden, M.J.2
Chowdhry, B.Z.3
-
5
-
-
79960329607
-
Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: An AFM and Raman investigation
-
Rogueda PGA, Price R, Smith T, et al. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation. J. Colloid Interface Sci. 2011; 361: 649-655.
-
(2011)
J. Colloid Interface Sci.
, vol.361
, pp. 649-655
-
-
Rogueda, P.G.A.1
Price, R.2
Smith, T.3
-
6
-
-
84886829445
-
-
espiratory Drug Delivery, Palm Deresrt, CA
-
Young PM, Price R, Jones S, et al. Investigation into Drug and Excipient Interaction in Dry Powder Inhaler Combination Products. Respiratory Drug Delivery, Palm Deresrt, CA, 2004.
-
(2004)
Investigation into Drug and Excipient Interaction in Dry Powder Inhaler Combination Products
-
-
Young, P.M.1
Price, R.2
Jones, S.3
-
7
-
-
0034465395
-
Salmeterol and fluticasone propionate given as a combination
-
Kirby S, Falcoz C, Daniel MJ, et al. Salmeterol and fluticasone propionate given as a combination. Eur. J. Clinic. Pharmacol. 2001; 56: 781-791.
-
(2001)
Eur. J. Clinic. Pharmacol.
, vol.56
, pp. 781-791
-
-
Kirby, S.1
Falcoz, C.2
Daniel, M.J.3
-
8
-
-
45949112470
-
In vitro/in vivo comparisons in pulmonary drug delivery
-
Newman SP, Chan HK,. In vitro/in vivo comparisons in pulmonary drug delivery. J. Aerosol Med. Pulm. Drug Del. 2008; 21: 77-84.
-
(2008)
J. Aerosol Med. Pulm. Drug Del.
, vol.21
, pp. 77-84
-
-
Newman, S.P.1
Chan, H.K.2
-
9
-
-
77956419131
-
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model
-
Haghi M, Young PM, Traini D, et al. Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model. Drug Dev. Ind. Pharm. 2010; 36: 1207-1214.
-
(2010)
Drug Dev. Ind. Pharm.
, vol.36
, pp. 1207-1214
-
-
Haghi, M.1
Young, P.M.2
Traini, D.3
-
10
-
-
59849094684
-
The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa
-
Grainger CI, Greenwell LL, Martin GP, et al. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. Eur. J. Pharm. Biopharm. 2009; 71: 318-324.
-
(2009)
Eur. J. Pharm. Biopharm.
, vol.71
, pp. 318-324
-
-
Grainger, C.I.1
Greenwell, L.L.2
Martin, G.P.3
-
11
-
-
73949146929
-
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: A randomized controlled trial
-
Dalby C, Polanowski T, Larsson T, et al. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. Respir. Res. 2009; 10: 1-11.
-
(2009)
Respir. Res.
, vol.10
, pp. 1-11
-
-
Dalby, C.1
Polanowski, T.2
Larsson, T.3
-
12
-
-
84886846467
-
-
Date last updated: 16 Jun 2013. [Accessed Jul 2013.]
-
Wishart D., Fluticasone propionate. 2005. Date last updated: 16 Jun 2013. [Accessed Jul 2013.] Available from URL: http://www.drugbank.ca/drugs/DB00588
-
(2005)
Fluticasone Propionate
-
-
Wishart, D.1
-
13
-
-
0037458930
-
Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3
-
Florea BI, Cassara ML, Junginger HE, et al. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J. Control Release 2003; 87: 131-138.
-
(2003)
J. Control Release
, vol.87
, pp. 131-138
-
-
Florea, B.I.1
Cassara, M.L.2
Junginger, H.E.3
-
14
-
-
0035526162
-
Estimation of aqueous solubility of chemical compounds using E-State indices
-
Tetko IV, Tanchuk VY, Kasheva TN, et al. Estimation of aqueous solubility of chemical compounds using E-State indices. J. Chem. Inf. Comput. Sci. 2001; 41: 1488-1493.
-
(2001)
J. Chem. Inf. Comput. Sci.
, vol.41
, pp. 1488-1493
-
-
Tetko, I.V.1
Tanchuk, V.Y.2
Kasheva, T.N.3
-
16
-
-
0036793972
-
Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma
-
Ketchell RI, Jensen MW, Lumley P, et al. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J. Allergy Clin. Immunol. 2002; 110: 603-606.
-
(2002)
J. Allergy Clin. Immunol.
, vol.110
, pp. 603-606
-
-
Ketchell, R.I.1
Jensen, M.W.2
Lumley, P.3
-
17
-
-
33751062503
-
Rapid effects of inhaled corticosteroids in acute asthma
-
Rodrigo GJ,. Rapid effects of inhaled corticosteroids in acute asthma. Chest 2006; 130: 1301-1311.
-
(2006)
Chest
, vol.130
, pp. 1301-1311
-
-
Rodrigo, G.J.1
-
18
-
-
0031764410
-
Efficacy of inhaled corticosteroids in asthma
-
Barnes PJ,. Efficacy of inhaled corticosteroids in asthma. J. Allergy Clin. Immunol. 1998; 102: 531-538.
-
(1998)
J. Allergy Clin. Immunol.
, vol.102
, pp. 531-538
-
-
Barnes, P.J.1
-
19
-
-
0026520491
-
Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin
-
Whelan CJ, Johnson M,. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br. J. Pharmacol. 1992; 105: 831-838.
-
(1992)
Br. J. Pharmacol.
, vol.105
, pp. 831-838
-
-
Whelan, C.J.1
Johnson, M.2
-
20
-
-
0029963586
-
Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep
-
Peterson BT, Griffith DE, Connelly JC, et al. Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep. J. Appl. Physiol. 1996; 80: 1666-1673.
-
(1996)
J. Appl. Physiol.
, vol.80
, pp. 1666-1673
-
-
Peterson, B.T.1
Griffith, D.E.2
Connelly, J.C.3
-
21
-
-
2342465008
-
Airway epithelial integrity is protected by a long-acting β2-adrenergic receptor agonist
-
Coraux C, Kileztky C, Polette M, et al. Airway epithelial integrity is protected by a long-acting β2-adrenergic receptor agonist. Am. J. Respir. Cell Mol. Biol. 2004; 30: 605-612.
-
(2004)
Am. J. Respir. Cell Mol. Biol.
, vol.30
, pp. 605-612
-
-
Coraux, C.1
Kileztky, C.2
Polette, M.3
|